You are here:Home-Chemical Inhibitors & Agonists-Nuclear Receptor/Transcription Factor-Estrogen Receptor/ERR-SMIP34
SMIP34

Chemical Structure : SMIP34

CAS No.: 946262-80-2

SMIP34 (PELP1 inhibitor SMIP34, SMIP-34)

Catalog No.: PC-49259Not For Human Use, Lab Use Only.

SMIP34 (Small Molecule Inhibitor of PELP1 34) is a first-in-class, small molecule inhibitor of estrogen receptor (ER) coregulator PELP1, binds to (Kd=37.4 uM) and reduces PELP1 oncogenic functions.

Packing Price Stock Quantity
50 mg Get quote
100 mg Get quote
250 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

    Biological Activity

    SMIP34 (Small Molecule Inhibitor of PELP1 34) is a first-in-class, small molecule inhibitor of estrogen receptor (ER) coregulator PELP1, binds to (Kd=37.4 uM) and reduces PELP1 oncogenic functions.
    SMIP34 binds to PELP1 aa 601-866 region, and S712P mutation disrupts this interaction.
    SMIP34 treatment significantly reduced the E2 induced activity of the ERE reporter in ZR75 WT- ER+ BC model cells.
    SMIP34 directly interacts with PELP1, interferes with PELP1 co-activation functions, and promotes PELP1 degradation via the proteasomal pathway with EC50 of 5-10 uM in different BC model cell lines.
    SMIP34 showed potent activity with an IC50 ranging from 5-10 uM in MTT assays.
    SMIP34 treatment significantly reduced the E2 induced activity of the ERE reporter in ZR75 WT- ER+ BC model cells.
    SMIP34 directly interacts with PELP1, interferes with PELP1 co-activation functions, and promotes PELP1 degradation via the proteasomal pathway with EC50 of 5-10 uM in different BC model cell lines in triplicate and utilized multiple WT- ER+ and TR- BC cell lines, and knock-down of PELP1 significantly reduced the activity of SMIP34.
    SMIP34 significantly reduced the colony formation ability of MT- ER+ BC model cells with an IC50 of 5-10 uM, reduced the invasiveness of MT- ER+ BC models and promoted apoptosis.
    SMIP34 downregulates ER signaling and enhances apoptotic pathways, SMIP34 is effective in limiting proliferation of WT- ER+ PDX tumor tissue, also reduces the proliferation of MT- ER+ CDX and PDX tumor tissue in explant assays.
    SMIP34 (10-20mg/kg, daily i.p.) reduced WT- and MT- ER+ BC CDX and PDX tumor growth in vivo, significantly reduced the tumor progression and tumor weight in mice with ZR75 xenografts.

    Physicochemical Properties

    M.Wt 443.881
    Formula C20H15ClFN5O2S
    Appearance Solid
    CAS No.
    Storage
    Solide Powder
    -20°C 12 Months; 4°C 6 Months
    In Solvent
    -80°C 6 Months; -20°C 6 Months
    Shipping
    Solubility

    10 mM in DMSO

    Chemical Name/SMILES

    2-((1-(4-chlorophenyl)-4-oxo-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-6-yl)thio)-N-(4-fluorobenzyl)acetamide

    References

    1. Kristin A Altwegg, et al. Cancer Res. 2022 Aug 11;CAN-22-0698.

    Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

    Contact Us sales@probechem.com

    Bulk Inquiry

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • *Additional Information:

    Get Quote

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • Additional Information: